A COMPOSITION COMPRISING FRAXIDIN ISOLATED FROM FRAXINUS RHYNCHOPHYLLA FOR PREVENTING AND TREATING TOXOPLASMOSIS

摘要

A composition comprising fraxidin isolated from Fraxinus rhynchophylla is provided to show inhibitory effect on toxoplasma, thereby being usefully used as a pharmaceutical composition for preventing and treating toxoplasmosis. A pharmaceutical composition for preventing and treating toxoplasmosis comprises 0.1-50 wt.% of fraxidin isolated from Fraxini Cortex of Fraxinus rhynchophylla and represented by a formula(1). An antiprotozoan supplement agent for preventing and treating toxoplasma comprises the fraxidin.